Top in GI: Female representation in leadership; draft guidance for celiac disease drugs
Click Here to Manage Email Alerts
In a Healio video exclusive, Aasma Shaukat, MD, MPH, a professor of population health at NYU Grossman School of Medicine, discussed her efforts to advance female representation in leadership roles.
She also shared advice for other women in medicine, encouraging them to “always be asking for a seat at the table,” and to make a concerted effort to “elevate the whole field.” It was the top story in gastroenterology last week.
The second top story was about the FDA’s draft guidance for sponsors who are developing drugs for celiac disease. It includes considerations for clinical trial eligibility criteria, trial design features, efficacy evaluations, and clinical outcome and safety assessments.
Read these and more top stories in gastroenterology below:
VIDEO: Women should always ask for a seat at the table, says GI expert
In this video, Shaukat shares advice for advancing female representation in gastroenterology. Read more.
FDA releases draft guidance for drugs under development for celiac disease
The FDA has issued a draft guidance for sponsors developing drugs as adjunctive treatment to a gluten-free diet in adults with celiac disease. Read more.
Fatigue in patients with advanced NASH may increase risk for adverse events
Worse fatigue at baseline among patients with nonalcohol steatohepatitis-related advanced fibrosis and cirrhosis correlated with a higher risk for adverse clinical events, according to published results. Read more.
FDA approves Sun Pharmaceuticals’ generic mesalamine extended-release capsules for UC
Sun Pharmaceutical Industries received FDA approval of its abbreviated new drug application for mesalamine extended-release capsules indicated for use in ulcerative colitis, according to a press release. Read more.
Cardiovascular disease more prevalent in lean vs. overweight, obese patients with NAFLD
Lean patients with nonalcoholic fatty liver disease were at greater risk for cardiovascular and chronic kidney disease compared with overweight or obese patients, according to a researcher at the Digestive Disease Week 2022 media briefing. Read more.